All orders ship from the United States
The final product is not reviewed by the FDA for safety, effectiveness, or bioequivalence
Off-label benefits of GLP-1s are also being evaluated, some of which include improvement in inflammation and arthritis issues, metabolic disorders, addiction disorders (gambling, alcoholism, drugs) and possible benefits for hormone-driven cancers
Triple-hormone-receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2 trial Sanyal AJ, et al
Foods get a point value based on calories, protein, fiber, sugar, and fat
We are proud to announce the first-ever launch of Semaglutide injections in Myanmar under the brand name ORSEMA a breakthrough therapy for diabetes and weight management that is transforming global healthcare standards